CNTX
Context Therapeutics Inc.
-0.01 (-3.48%)0.37USD585K成交股數33.6M市值–本益比(近四季)13.7股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 1.2M+324% | 840K+136% | 152K | 290K | 293K | 356K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 12.5M | 7.0M | 8.7M | 7.8M | 3.5M | 2.5M | 16.8M | 1.4M | 2.0M | 4.5M | 3.5M | 4.5M |
| 銷售管理費用 | 2.4M | 2.3M | 1.9M | 1.9M | 2.1M | 1.8M | 1.9M | 1.7M | 1.9M | 1.7M | 1.8M | 2.1M |
| 營業利益 | −15.0M+171% | −9.3M+117% | −10.6M-43% | −9.8M+216% | −5.5M+45% | −4.3M-30% | −18.7M+253% | −3.1M-54% | −3.8M | −6.2M | −5.3M | −6.7M |
| 營業利益率 | – | – | – | – | – | – | -1,503.7% | -367.6% | -2,509.7% | -2,128.0% | -1,804.6% | -1,875.0% |
| 稅後淨利 | −14.6M+218% | −8.7M+160% | −9.7M-44% | −8.8M+292% | −4.6M+25% | −3.3M-43% | −17.5M+248% | −2.3M-64% | −3.7M | −5.9M | −5.0M | −6.3M |
| 淨利率 | – | – | – | – | – | – | -1,403.9% | -268.3% | -2,407.5% | -2,022.7% | -1,708.8% | -1,774.3% |
| 稀釋 EPS | -0.15+200% | -0.09-400% | -0.10-55% | -0.09+125% | -0.05-78% | 0.03-108% | -0.22-29% | -0.04-90% | -0.23 | -0.37 | -0.31 | -0.40 |
| 稀釋股數 | 95.2M | 95.2M | 95.2M | 95.2M | 95.2M | 58.4M | 80.5M | 55.0M | 16.0M | 16.0M | 16.0M | 16.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 43.0M | 54.5M | 76.9M | 83.5M | 89.4M | 94.4M | 84.8M | 102M | 10.1M | 21.7M | 25.1M | 29.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 46.1M | 58.9M | 79.2M | 87.2M | 93.0M | 98.1M | 86.3M | 103M | 11.1M | 23.0M | 27.8M | 32.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 8.0M | 6.7M | 6.1M | 4.6M | 2.0M | 2.9M | 2.5M | 1.6M | 2.6M | 4.6M | 3.8M | 3.2M |
| 股東權益 | 38.2M | 52.2M | 73.2M | 82.5M | 91.0M | 95.3M | 83.9M | 101M | 8.4M | 18.4M | 24.0M | 28.7M |
| 負債比 | 17.3% | 11.3% | 7.6% | 5.3% | 2.1% | 2.9% | 2.9% | 1.6% | 23.6% | 20.0% | 13.5% | 10.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −11.4M | – | – | −5.0M+15% | – | – | – | −4.4M | – | – | −5.7M |
| 資本支出 | – | 37K | – | – | 34K | – | – | – | 0.00 | – | – | 0.00 |
| 自由現金流 | – | −11.5M | – | – | −5.1M+16% | – | – | – | −4.4M | – | – | −5.7M |
| 折舊攤銷 | – | 5K | – | – | 4K | – | – | – | 3K | – | – | 3K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -2,862.2% | – | – | -1,611.2% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −36.1M | –% | -0.38 | −26.4M |
| FY2024 | – | – | −26.7M | –% | -0.46 | −14.6M |
| FY2023 | 1.2M | +112.7% | −24.0M | -2,058.8% | -1.50 | −21.0M |
| FY2022 | 547K | -951.9% | −14.8M | -2,710.9% | -0.93 | −13.6M |
| FY2021 | −64K | – | −10.5M | 16,277.8% | -3.69 | −8.8M |
| FY2020 | – | – | 6.6M | –% | -3.96 | – |